Shire PLC Company Profile (NASDAQ:SHPG)

About Shire PLC

Shire PLC logoShire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. The Company focuses its development resources on projects in various therapeutic areas (TAs), including rare diseases, neuroscience, ophthalmics, hematology and gastrointestinal (GI), and focuses its early development projects primarily on rare diseases. Its products include VYVANSE/VENVANSE/ELVANSE/TYVENSE/ELVANSE VUXEN/ADUVANZ, ADDERALL XR, INTUNIV, LIALDA (mesalamine)/MEZAVANT(mesalazine), PENTASA (mesalamine), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant), CINRYZE C1 esterase inhibitor (human), GATTEX/REVESTIVE, NATPARA/NATPAR, FOSRENOL (lanthanum carbonate) and KALBITOR.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SHPG
  • CUSIP:
Key Metrics:
  • Previous Close: $199.44
  • 50 Day Moving Average: $195.03
  • 200 Day Moving Average: $178.92
  • Trailing P/E Ratio: 41.45
  • Foreward P/E Ratio: 13.07
  • P/E Growth: 1.08
  • Market Cap: $45.39B
  • Outstanding Shares: 227,599,000
  • Beta: 1.11
Additional Links:
Companies Related to Shire PLC:

Analyst Ratings

Consensus Ratings for Shire PLC (NASDAQ:SHPG) (?)
Ratings Breakdown: 2 Hold Ratings, 24 Buy Ratings
Consensus Rating:Buy (Score: 2.92)
Consensus Price Target: $239.67 (20.17% upside)

Analysts' Ratings History for Shire PLC (NASDAQ:SHPG)
DateFirmActionRatingPrice TargetDetails
8/17/2016Jefferies GroupReiterated RatingBuyView Rating Details
8/13/2016Shore CapitalReiterated RatingBuyView Rating Details
8/3/2016RBC Capital MarketsReiterated RatingOutperformView Rating Details
8/3/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
8/3/2016Leerink SwannReiterated RatingOutperform$213.00 -> $231.00View Rating Details
8/3/2016GuggenheimReiterated RatingNeutralView Rating Details
8/1/2016JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details
7/15/2016Piper Jaffray Cos.Reiterated RatingNeutral$174.00View Rating Details
7/12/2016BTIG ResearchReiterated RatingBuy$230.00View Rating Details
6/28/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details
6/15/2016Royal Bank Of CanadaReiterated RatingOutperformView Rating Details
6/9/2016Sanford C. BernsteinReiterated RatingOutperform$222.00View Rating Details
6/3/2016Morgan StanleyReiterated RatingOverweightView Rating Details
5/26/2016Stifel NicolausInitiated CoverageBuy$230.00View Rating Details
5/23/2016Bryan, Garnier & CoInitiated CoverageBuyView Rating Details
5/6/2016Liberum CapitalInitiated CoverageBuyView Rating Details
5/3/2016Cowen and CompanyReiterated RatingBuyView Rating Details
3/30/2016Bank of America Corp.Reiterated RatingBuyView Rating Details
2/26/2016Cantor FitzgeraldInitiated CoverageBuyView Rating Details
2/13/2016Northland SecuritiesReiterated RatingBuyView Rating Details
2/8/2016SusquehannaLower Price TargetPositive$280.00 -> $220.00View Rating Details
1/18/2016Credit Suisse Group AGUpgradeBuyView Rating Details
1/18/2016BNP ParibasUpgradeNeutral -> OutperformView Rating Details
11/3/2015HSBCUpgradeHold -> BuyView Rating Details
10/21/2015William BlairReiterated RatingOutperform$276.00View Rating Details
9/21/2015Barclays PLCUpgradeEqual Weight -> OverweightView Rating Details
7/16/2015Berenberg BankInitiated CoverageBuyView Rating Details
6/8/2015Deutsche Bank AGReiterated RatingBuyView Rating Details
5/6/2015Kepler Capital MarketsReiterated RatingBuyView Rating Details
1/12/2015S&P Equity ResearchDowngradeStrong-Buy -> BuyView Rating Details
1/5/2015Panmure GordonReiterated RatingBuyView Rating Details
10/27/2014CRT CapitalReiterated RatingBuy$225.00 -> $233.00View Rating Details
10/20/2014SunTrust Banks Inc.UpgradeNeutral -> Buy$269.00 -> $225.00View Rating Details
(Data available from 8/24/2014 forward)


Earnings History for Shire PLC (NASDAQ:SHPG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q216$3.03$3.38$2.28 billion$2.43 millionViewN/AView Earnings Details
4/29/2016Q1$3.05$3.19$1.71 billion$1.71 billionViewListenView Earnings Details
2/11/2016Q415$2.89$2.97$1.69 million$1.72 billionViewListenView Earnings Details
10/23/2015Q315$2.87$3.24$1.63 billion$1.58 billionViewListenView Earnings Details
7/23/2015Q215$2.81$2.63$1.59 billion$1.56 billionViewListenView Earnings Details
4/30/2015Q115$2.56$2.84$1.47 billion$1.49 billionViewN/AView Earnings Details
2/12/2015Q115$2.68$2.63$1.58 billionViewN/AView Earnings Details
10/24/2014Q314$2.47$2.93$1.46 billion$1.55 billionViewListenView Earnings Details
7/18/2014Q214$2.45$2.67$1.45 billion$1.50 billionViewN/AView Earnings Details
5/1/2014Q114$2.22$2.36$1.38 billion$1.35 billionViewN/AView Earnings Details
2/13/2014Q413$2.02$2.26$1.28 billion$1.33 billionViewN/AView Earnings Details
10/24/2013Q213$1.65$1.77$1.23 billion$1.24 billionViewN/AView Earnings Details
7/25/2013$1.60$1.79$1.21 billion$1.28 billionViewN/AView Earnings Details
5/2/2013Q113$1.56$1.63$1.21 billion$1.16 billionViewN/AView Earnings Details
2/14/2013Q412$1.58$1.58$1.20 billion$1.20 billionViewN/AView Earnings Details
10/25/2012$1.47$1.36ViewN/AView Earnings Details
8/1/2012$1.52$1.68ViewN/AView Earnings Details
4/26/2012$0.52$1.24ViewN/AView Earnings Details
2/9/2012$0.48$0.44ViewN/AView Earnings Details
10/28/2011$1.31$1.28ViewN/AView Earnings Details
7/28/2011$1.24$1.33ViewN/AView Earnings Details
4/28/2011$1.18$1.23ViewN/AView Earnings Details
2/10/2011$1.04$1.03ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Shire PLC (NASDAQ:SHPG)
Current Year EPS Consensus Estimate: $13 EPS
Next Year EPS Consensus Estimate: $15.26 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20167$2.76$3.17$3.01
Q2 20164$3.05$3.23$3.13
Q3 20164$3.00$3.43$3.14
Q4 20164$3.02$3.68$3.31
(Data provided by Zacks Investment Research)


Current Dividend Information for Shire PLC (NASDAQ:SHPG)
Annual Dividend:$0.79
Dividend Yield:0.40%
Payout Ratio:15.43% (Based on Trailing 12 Months of Earnings)
6.08% (Based on Current Year Consensus EPS Estimate)
5.18% (Based on Next Year Consensus EPS Estimate)

Dividend History for Shire PLC (NASDAQ:SHPG)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Shire PLC (NASDAQ:SHPG)
No insider trades for this company have been tracked by


Latest Headlines for Shire PLC (NASDAQ:SHPG)
News IconStock Trading Above Moving Averages: Shire plc (NASDAQ:SHPG) - Post News (NASDAQ:SHPG) - August 22 at 7:18 PM logoShire : Files 8K - Other Events (NASDAQ:SHPG) - August 22 at 11:57 AM logoAnalysts See Sales Of $22023.42 For Shire plc (NASDAQ:SHPG) - Investor Newswire (NASDAQ:SHPG) - August 21 at 11:19 AM
News IconDrug Manufacturers – Major: Shire plc (NASDAQ:SHPG) Position of the day (NASDAQ:SHPG) - August 20 at 11:22 AM logoShire: New Acquisition - Seeking Alpha (NASDAQ:SHPG) - August 19 at 10:19 AM
News IconUpdate on Shire plc (NASDAQ:SHPG) for the day (NASDAQ:SHPG) - August 18 at 7:39 PM
News IconLarge Cap Drug Manufacturers – Major: Shire plc (NASDAQ:SHPG) (NASDAQ:SHPG) - August 17 at 7:47 PM
News IconTop Gainers of the Day: Shire plc (NASDAQ:SHPG) from Drug Manufacturers – Major (NASDAQ:SHPG) - August 17 at 10:25 AM logoMartin Whitman's Third Avenue Management Purchases 8 Stocks (NASDAQ:SHPG) - August 12 at 7:31 PM
News IconShire Files 8K - Other Events (NASDAQ:SHPG) - August 11 at 7:57 PM
News IconIs Shire plc (NASDAQ:SHPG), a large market cap stock a smart buy? - Twin County News (NASDAQ:SHPG) - August 11 at 10:41 AM
News IconHC Stocks News Ring: Biogen Inc (BIIB), Shire PLC (ADR) (SHPG) - share market updates (press release) (NASDAQ:SHPG) - August 10 at 10:34 AM
News IconA look at a High Market Cap Stock: Shire plc, SHPG - The Daily Leicester (NASDAQ:SHPG) - August 10 at 10:34 AM logoSHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:SHPG) - August 9 at 10:39 AM logoVONVENDI, The First and Only Recombinant Treatment for Adults Affected by Von Willebrand Disease, Launches in the U.S. (NASDAQ:SHPG) - August 9 at 10:39 AM logo7:01 am Shire announces the U.S. launch of VONVENDI, the only recombinant treatment for adults living with von Willebrand disease (:VWD) (NASDAQ:SHPG) - August 9 at 10:39 AM logoVONVENDI, THE FIRST AND ONLY ... (NASDAQ:SHPG) - August 9 at 10:39 AM logoSHIRE PLC : Other Events, Financial Statements and Exhibits (form 8-K) (NASDAQ:SHPG) - August 8 at 7:38 PM
News IconIs Shire plc (NASDAQ:SHPG), a large market cap stock a smart buy? (NASDAQ:SHPG) - August 8 at 7:38 PM logoShire : Half-yearly Report (NASDAQ:SHPG) - August 8 at 12:11 PM logo2 ‘must-have’ healthcare stocks after today’s updates? (NASDAQ:SHPG) - August 8 at 12:11 PM logoWhat Are Analysts Recommending for Shire? (NASDAQ:SHPG) - August 8 at 12:11 PM
News IconLeading stocks in today’s market: Shire plc (NASDAQ:SHPG) (NASDAQ:SHPG) - August 5 at 7:39 PM logo2Q16 Results of Shire’s Baxalta Acquisition (NASDAQ:SHPG) - August 5 at 10:27 AM logoStrong Sell Calls For Shire plc (NASDAQ:SHPG) At 0 - Investor Newswire (NASDAQ:SHPG) - August 4 at 7:52 PM
News IconHot Stock under Consideration: Shire plc (NASDAQ:SHPG) - News Oracle (NASDAQ:SHPG) - August 4 at 7:52 PM logoWhat’s behind Shire’s 2Q16 Earnings Surprise? (NASDAQ:SHPG) - August 4 at 7:52 PM logoHow Did Shire’s Franchises Perform in 2Q16? (NASDAQ:SHPG) - August 4 at 7:52 PM logoSimply the best growth stocks in the FTSE 100? (NASDAQ:SHPG) - August 4 at 10:37 AM logoShire Plc :SHPG-US: Earnings Analysis: Q2, 2016 By the Numbers : August 4, 2016 (NASDAQ:SHPG) - August 4 at 10:37 AM logoStocks Movements Activity: Great Basin Scientific, Inc. (NASDAQ ... - Street Updates (NASDAQ:SHPG) - August 3 at 7:47 PM logoShire plc (SHPG) Raising PT - Leerink - (NASDAQ:SHPG) - August 3 at 7:47 PM logoShire Plc (SHPG) Flemming Ornskov on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:SHPG) - August 3 at 7:47 PM logoSHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits (NASDAQ:SHPG) - August 3 at 7:47 PM logoShire plc (SHPG) Raising PT - Leerink (NASDAQ:SHPG) - August 3 at 10:42 AM logoUpdate on Analyst Recommendations for Alexion (NASDAQ:SHPG) - August 3 at 10:42 AM logoShire reports 2Q loss (NASDAQ:SHPG) - August 2 at 7:46 PM logoShould Shareholders Heed Shire PLC (NASDAQ:SHPG)’s Advice? (NASDAQ:SHPG) - August 2 at 7:46 PM logoShire revenues up 56%; Non-GAAP EPS up 29% in Q2; updates guidance (NASDAQ:SHPG) - August 2 at 7:46 PM logoShire plc (SHPG) Tops Q2 EPS by 35c; Guides FY16 EPS Above Views (NASDAQ:SHPG) - August 2 at 7:46 PM logoAnalysts Ranking Previews: Medtronic plc (NYSE:MDT) , Shire plc (NASDAQ:SHPG) - Street Updates (NASDAQ:SHPG) - August 2 at 12:22 PM logoShire PLC beats by $0.39, beats on revenue (NASDAQ:SHPG) - August 2 at 7:31 AM logoShould Shareholders Heed Shire PLC (NASDAQ:SHPG)'s Advice? - Market Exclusive (NASDAQ:SHPG) - August 1 at 7:09 PM logoWhat to Expect When Shire (SHPG) Reports Q2 Earnings Tomorrow (NASDAQ:SHPG) - August 1 at 7:09 PM logoThe Shire Vs. Allergan War Has Begun - Seeking Alpha (NASDAQ:SHPG) - August 1 at 12:02 PM logoShould You Buy Shire plc (SHPG) Ahead of Earnings? - Nasdaq (NASDAQ:SHPG) - August 1 at 12:02 PM logoSHIRE ANNOUNCES FDA APPROVAL OF ... (NASDAQ:SHPG) - August 1 at 12:02 PM logoShould You Buy Shire plc (SHPG) Ahead of Earnings? (NASDAQ:SHPG) - August 1 at 12:02 PM logoShire : SHP626 (Volixibat) Receives FDA ... (NASDAQ:SHPG) - July 29 at 7:34 PM
News IconShire Recommends ADS Holders Reject TRC Capital's ?Mini-Tender Offer (NASDAQ:SHPG) - July 29 at 7:34 PM


Shire PLC (NASDAQ:SHPG) Chart for Wednesday, August, 24, 2016

Last Updated on 8/24/2016 by Staff